Julie Deterra, | |
1103 Kempton St, New Bedford, MA 02740-1530 | |
(508) 990-3765 | |
Not Available |
Full Name | Julie Deterra |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 1103 Kempton St, New Bedford, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1225311335 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 22294 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Julie Deterra, 1103 Kempton St, New Bedford, MA 02740-1530 Ph: (508) 990-3765 | Julie Deterra, 1103 Kempton St, New Bedford, MA 02740-1530 Ph: (508) 990-3765 |
News Archive
A compound found in the skin of grapes and used to make red wine may help fight severe malaria, raising hopes of finding a new adjunctive therapy against an illness that kills an estimated 1 million people a year, according to a study presented today at The American Society of Tropical Medicine and Hygiene 59th Annual Meeting.
The long-term, positive benefits of transplanted allogenic (other-donated) smooth muscle cells (SMCs) to repair cardiac tissues after myocardial infarction (MI) have been enhanced by the addition of interleukin 10 (IL-10) to the transplanted cells, report researchers in Canada.
Ohio is one step closer to implementing changes aimed at better coordinating medical care for some of the state's sickest and most expensive patients. Gov. John Kasich's administration wants to streamline the way health care is delivered to Ohioans enrolled in both Medicaid and Medicare. The state submitted a plan this spring to the federal government to better coordinate care for almost 114,000 so-called "dual-eligible" individuals living in seven urban regions.
During a stop in Indonesia on Tuesday as part of his 10-day Asia-Pacific tour, President Barack Obama together with Indonesian President Susilo Bambang Yudhoyono announced a U.S.-Indonesia partnership that will encompass a variety of key issues such as science, technology, health and trade.
Quark Pharmaceuticals, Inc., a world leader in the discovery and development of RNAi-based therapeutics, today announced that it has granted Novartis an option to obtain an exclusive worldwide license to develop and commercialize its p53 temporary inhibitor siRNA drug QPI-1002, currently the subject of a Phase II clinical trial.
› Verified 7 days ago
Kyle Emanuel Roque, DR Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1103 Kempton St, New Bedford, MA 02740 Phone: 508-990-3765 | |
Mrs. Ana Claudia Dacunha-cole, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2170 Acushnet Ave, New Bedford, MA 02745 Phone: 508-995-6408 | |
Stefani Lynne Mcmillian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 824 Purchase St, New Bedford, MA 02740 Phone: 508-992-2422 | |
Mrs. Celeste Dubois, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 Page St, New Bedford, MA 02740 Phone: 508-997-1515 | |
Dr. Rosary Marie Demello, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 Acushnet Ave, New Bedford, MA 02745 Phone: 508-995-2653 | |
Benjamin Taylor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 838 Pleasant St, New Bedford, MA 02740 Phone: 508-984-4434 | |
Amy Lynn Solomon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1103 Kempton St, New Bedford, MA 02740 Phone: 508-643-2007 Fax: 508-990-7780 |